Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
Background Stroke is the most serious clinical consequence of atrial fibrillation, which is the
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
GYH Lip, SA Mitchell, X Liu… - International …, 2016 - internationaljournalofcardiology.com
Background Stroke is the most serious clinical consequence of atrial fibrillation, which is the
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
GYH Lip, SA Mitchell, X Liu, LZ Liu… - International …, 2016 - pubmed.ncbi.nlm.nih.gov
Background Stroke is the most serious clinical consequence of atrial fibrillation, which is the
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
GYH Lip, SA Mitchell, X Liu, LZ Liu, H Phatak… - International Journal of …, 2016 - infona.pl
Stroke is the most serious clinical consequence of atrial fibrillation, which is the most
common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) have …
common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) have …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
GYH Lip, SA Mitchell, X Liu, LZ Liu, H Phatak… - International Journal of …, 2016 - vbn.aau.dk
BACKGROUND: Stroke is the most serious clinical consequence of atrial fibrillation, which is
the most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants …
the most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants …
Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran …
GY Lip, SA Mitchell, X Liu, LZ Liu, H Phatak… - … Journal of Cardiology, 2015 - europepmc.org
Background Stroke is the most serious clinical consequence of atrial fibrillation, which is the
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …
most common cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) …